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Case report
Twenty years ago, a 50-year-old woman with multiple 
cancers suffered a multifocal ductal carcinoma in situ with 
microinvasion that was treated by mastectomy with axillary 
lymph node dissection, followed by radiotherapy and hor-
mone therapy. One year later, she developed a well-
differentiated leiomyosarcoma on her left arm measuring 
2.5 cm, which was treated by complete surgical excision. 
Three years later, she again developed multifocal ductal 
carcinoma in situ with microinvasion of  the left breast, this 
time treated by mastectomy and axillary lymph-node dis-
section. She was free of  tumor for sixteen years until 2009, 
when she was diagnosed with an abdominal and retroperi-
toneal leiomyosarcoma extending from the inner side of  the 
iliac wing to the left oblique muscle of  the abdominal wall. 
The tumor measured 5x5x4 cm and had a proliferation 
index (Ki67) of  40%. The treatment consisted in a wide 
surgical excision followed by chemotherapy. Only one year 
later, she relapsed with a bifocal tumor: one part on the left 
abdominal wall measuring 3x3.3x3.3 cm, and the other 
part below the first on the inner side of  the left iliac wing 
measuring 6x5.5x6 cm.
Preoperative staging included a F18-deoxyglucose (FDG) 
PET-CT to assess tumor extension and metastatis. The 
PET-CT acquisition was in 3D-mode, 60 minutes after 
intravenous injection of  4.5 MBq/kg 18F-FDG. A dual-
phase study was also performed on the pelvis 150 min after 
the injection.
The whole-body PET-CT scan found intense uptake of  
the bifocal known leiomyosarcoma of  the left abdominal 
wall. Fortuitously, another focal uptake on the uterus was 
found (Figs. 1A, D). The dual time-point imaging showed 
an increased FDG uptake; the maximum Standard Uptake 
Value was 8.5 kBq/ml one hour after injection and 12.3 
kBq/ml 150 min later. PET-CT scan was completed by a 
3T-MRI scan with T1-FAT-SAT and T2 sequences after 
gadolinium injection. The MRI could not exclude malig-
nancy of  the uterine mass.
The multidisciplinary cancer committee decided to per-
form a large excision of  the abdominal tumor with hyster-
ectomy during the same surgery. 
Histology confirmed the bifocal, FNCLCC grade-3 
leiomyosarcoma with a mitotic activity of  40 mitoses/10 
HPF and a high Ki67 index of  about 50-60%. The leio-
myosarcoma was estrogen-receptor-negative (Figs. 1B, C).
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The histological examination of  the uterine nodule re-
vealed a 1.5-cm, well-circumscribed tumor composed of  
spindle cells with dense eosinophilic cytoplasm and en-
larged, often bizarre single or multiple hyperchromatic nu-
clei without necrosis or myometrial invasion. Tumor cells 
were caldesmon, desmine, and smooth-muscle-actine posi-
tive, corresponding to the immunohistochemical phenotype 
of  smooth muscle. The Ki67 level was low, with a maxi-
mum value of  15%. The mitotic activity was 1 mitosis/10 
HPF. This tumor expressed estrogen receptors, whereas the 
leiomyosarcoma did not. Diagnosis was atypical (bizarre/
symplastic) leiomyoma of  the uterus, a benign variant of  
uterine leiomyoma (Figs. 1E, F).
Discussion
This case shows that atypical (bizarre) uterine leiomyoma 
can be suspected on FDG PET-CT due to glucose hyper-
metabolism. We think that despite the benign behavior of  
this kind of  tumor, the focal uptake may be explained by 
the relatively high cellularity of  the tissue and can be seen 
as a sign of  increased proliferative and metabolic activi-
ty—as shown with the Ki67 level, which focally achieved 
15% in the presence of  very rare mitotic figures. 
In view of  the clinical history of  the patient, who has a 
tendency to develop multiple malignant tumors, we should 
also discuss the possibility of  a precancerous small tumor in 
statu nascendi, with a particular metabolic signature on 
FDG PET-CT. 
Further comparative investigations involving histopa-
thology and imaging should try to find out whether FDG 
PET-CT could help in assessing the category of  uterine 
nodules, particularly those with increased metabolic and 
proliferative activity, in order to understand the gray-zone 
tumors better, as there are atypical leiomyomas and smooth 
muscle tumors of  uncertain malignant potential (STUMP).
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Figure 1. 50-year-old woman with carcinoma in situ (20 and 16 years ago) and leiomyosarcoma on the left arm (19 years ago). 
She recently developed another leiomyosarcoma of the left abdominal wall. FDG-PET-CT shows intense uptake of the recur-
rent tumor on the abdominal wall muscle and inner side of the iliac wing (A: axial CT, PET on the first line, fused and 
maximum-intensitiy projection [MIP] on the second line). Histology confirmed a leiomyosarcoma with coagulative necrosis; 
H&E staining x200 (B) and x400 (C). The same FDG-PET-CT showed abnormal focal uptake in the uterine body (D: axial CT, 
PET on the first line, fused and MIP on the second line). Histology revealed a uterine atypical (bizarre) leiomyoma with bizarre 
single or multiple hyperchromatic nuclei; H&E x100 (E) and x400 (F).
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